TMDX logo
TMDXNASDAQ

TransMedics Group, Inc.

Healthcare & PharmaceuticalsUS(United States)

Price history

Key statistics

Last Close
Previous Close
52W High
52W Low

Business profile

TransMedics Group, Inc. is a pioneering medical technology company dedicated to revolutionizing organ transplant therapy for patients suffering from end-stage organ failure. The company's core innovation is the Organ Care System (OCS), a sophisticated portable platform designed to maintain donor organs outside the body under near-physiologic conditions. This proprietary technology aims to significantly improve organ viability and expand the pool of usable donor organs. The OCS platform encompasses specialized solutions for different organs, including the OCS LUNG for lung transplantation, OCS Heart for both standard criteria and donation-after-circulatory-death hearts, and OCS Liver for liver transplantation. Beyond its device offerings, TransMedics provides comprehensive organ management and logistics services through its National OCS Program, a turnkey solution that handles organ retrieval, transportation via air and ground, and overall coordination. This integrated approach positions TransMedics as a leader in advancing the field of organ transplantation by addressing critical limitations in traditional cold storage preservation and enabling more organs to be successfully transplanted, ultimately aiming to save and improve more lives.